Research and Reports in Urology, published by DOVE MEDICAL PRESS LTD, is a premier journal dedicated to the dissemination of cutting-edge research and clinical advancements in the field of urology. With an impressive impact factor and a recognized status as Q2 within the urology category, this journal offers a vital platform for researchers, practitioners, and students eager to engage with the latest findings and methodologies. Since its inception in 2009, the journal has embraced an Open Access model, ensuring that critical research is freely available to the global community, thereby fostering collaboration and innovation in urological science. Based in New Zealand, it operates within a robust international framework, allowing for a diverse range of contributions that address pressing issues in urology and enhance professional knowledge. Researchers are encouraged to submit their work and become part of this influential discourse, as the journal continues to navigate the rapidly evolving landscape of urological health from 2012 to 2024 and beyond.

The Central European Journal of Urology, published by the Polish Urological Association, serves as a vital platform for the dissemination of cutting-edge research in the field of urology. Established in 2009 and continuing through 2024, this journal aims to foster innovation and collaboration among researchers, clinicians, and students by offering a forum for high-quality, peer-reviewed articles that highlight advancements in urological science and practice. Currently holding a Scopus rank of #68 out of 120 in the Medicine_Urology category, and a 2023 quartile ranking of Q3, it is positioned to provide valuable insights into emerging trends and techniques. Although being a subscription-based journal, it remains crucial for professionals seeking to stay updated on the latest developments in urology, contributing significantly to the global conversation in this specialty. With its strong ties to the academic community and dedication to excellence, the Central European Journal of Urology continues to be an indispensable resource for those advancing knowledge and practice in urology.

Asian Journal of Urology is a premier open-access scholarly journal dedicated to advancing the field of urology. Published by Elsevier Singapore Pte Ltd, this journal provides a platform for researchers, clinicians, and students to share impactful findings and innovative practices within urological sciences. Since its inception in 2014, it has established itself as a significant contributor to the discourse in urology, achieving a commendable Q2 ranking in the category of Urology for 2023 and securing the 41st position out of 120 in Scopus rankings, placing it in the 66th percentile amongst its peers. With a commitment to ensuring broad accessibility, all articles are freely available online, promoting widespread dissemination of knowledge. The journal aims to publish high-quality research that informs clinical practices and contributes to the development of urological sciences, making it an essential resource for professionals and scholars in the field.

European Urology Focus is a premier journal published by Elsevier, dedicated to advancing the field of urology. With its inception dating back to 2015 and a convergence period extending through 2024, this journal has rapidly established itself as a leading platform within the medical community, boasting an impressive Scopus ranking of #5 out of 120 in Urology, placing it in the 96th percentile. The journal is recognized for its impactful contributions to urological research, and it is classified in the prestigious Q1 category for Urology in 2023. Based in the Netherlands, European Urology Focus prioritizes innovative research, reviews, and clinical observations, catering not only to seasoned professionals but also to emerging scholars and practitioners in the field. While traditionally a subscription-based journal, it offers flexible access options tailored for its diverse readership. With a commitment to enhancing knowledge and improving patient outcomes in urological health, European Urology Focus stands as a vital resource for those engaged in this essential area of medicine.

Translational Andrology and Urology is a premier journal published by AME Publishing Company, dedicated to advancing research in the fields of reproductive medicine and urology. Established in 2012 and gaining prominence with its Q2 rankings in both the reproductive medicine and urology categories as of 2023, this journal serves as a vital platform for disseminating groundbreaking studies and clinical advancements. With an ISSN of 2223-4683 and an E-ISSN of 2223-4691, it is indexed in Scopus, standing at a distinguished rank of #40/120 in Urology and #33/90 in Reproductive Medicine. Located in Hong Kong, the journal reflects a commitment to open access and international collaboration, providing researchers, professionals, and students with critical insights and updates in these dynamic fields. As a leading resource, Translational Andrology and Urology invites contributions that explore innovative approaches that can enhance patient care and clinical practices.

Actas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.

The Journal of Urology stands as a premier publication in the field of urology, dedicated to advancing the understanding and treatment of urological diseases. Published by Lippincott Williams & Wilkins, this esteemed journal has maintained a strong presence since its inception in 1945, converging research and clinical practice until 2024. With an impressive impact factor that underscores its relevance and influence in the field—ranking 4th out of 120 in Urology according to Scopus—this journal is a vital resource for clinicians, researchers, and students alike. As a Q1 journal in its category for 2023, it boasts a high degree of visibility and rigorous peer-review standards, making it an essential reading for those wishing to stay abreast of the latest discoveries and technological advancements in urological health. Although it does not offer open access, the journal's commitment to disseminating high-quality research ensures its continued impact on both the academic community and clinical practice.

Urology Annals, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to advancing the field of urology through high-quality research and clinical insights. Established in India in 2009, this journal serves as a vital platform for communication among urologists, researchers, and medical professionals, aiming to enhance understanding and innovation in urological sciences. With an ISSN of 0974-7796 and an E-ISSN of 0974-7834, the journal offers unrestricted access to its content, fostering knowledge dissemination and collaboration across the global medical community. Currently ranked in the Q3 category within urology and holding a Scopus rank of #79/120, Urology Annals showcases significant contributions that align with its mission to publish original research, reviews, and case reports that address contemporary challenges in urology. The journal's ongoing commitment to remaining a leading resource in the field is reflected through its convergence of years from 2010 to 2024, ensuring that it stays at the forefront of the latest urological advancements.

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

Urological Science, published by Lippincott Williams & Wilkins, is a prominent open-access journal that has been a vital resource for the Urology field since its establishment in 2010. With a focus on innovative research and advancements in urological science, the journal aims to disseminate significant findings and encourage dialogue among physicians, researchers, and healthcare professionals worldwide. The journal has achieved a commendable Q3 rank within its category according to the latest quartiles released in 2023 and holds a Scopus rank of #80 out of 120 in the Medicine Urology field, placing it in the 33rd percentile. By providing an open-access platform, Urological Science ensures that vital research is easily accessible to a global audience, supporting the ongoing advancements in urological healthcare and education. As the landscape of urology evolves, this journal remains an essential vehicle for sharing knowledge and improving patient outcomes, making it an invaluable resource for anyone invested in the future of urological science.